3rd Annual Biomarkers Congress
14th & 15th May 2008, The Midland Hotel, Manchester, UK
3rd Annual Biomarkers Congress is administered by Osney Media.
Next Event
The 3rd Annual Biomarkers Congress
Wednesday 14th May 2008 to Thursday 15th May 2008
The Midland Hotel, Manchester
More
Solution Providers

Oxford Global Conferences’ strict delegate screening criteria and one to one meeting selection facility allow you to reach a large number of pre-qualified Biomarkers decision makers and make the most of your time at the event.

Read More
Speakers

The 3rd Annual Biomarkers Congress consists of a unique blend of presentations, round table discussions and one to one business meetings. If you have a cutting edge case study or a thought provoking presentation join us at the event.

Read More
Speakers from

Pfizer

N.V. Organon

Bristol Myers Squibb Company

Astra Zeneca

Novartis Pharma AG

Bayer Healthcare

F. Hoffmann-La Roche

Boehringer Ingelheim Germany Schering AG
Featured Speakers
Iman El-Hariry,
Group Director, Oncology MDC, Europe, GlaxoSmithKline R&D
Dorothee Foernzler,
Biomarker - Experimental Medicine Leader F.Hoffmann-La Roche
Stuart Freeman,
Director of Worldwide Toxicology, GlaxoSmithKline UK
Nicolas Frey,
Head of the Modeling and Simulation Group, F. Hoffmann-La Roche
William Gallagher,
Associate Professor, University College Dublin
Antony Gee,
Head of PET and Radiotracer Development, GlaxoSmithKline
Martin Grigorov,
Head of Bioinformatics, Nestle Research Centre
Ehud Hauben,
Head of Molecular Medicine Unit, Clinical Sciences and Biomarkers, Exploratory Medicine, Merck Serono Research
Hermann-Josef Huss,
Head, Data Acquisition & Management Europe & Overseas, Bayer Healthcare
Jeanne Kehren,
Head of Integrated Analysis, Biomarker Development, Novartis Pharma AG
Bernard Leblanc,
Head, Regulatory Submissions & External Relations Safety Sciences, Pfizer
Ruth March,
Personalized Healthcare Science & Technology Director, Personalized Healthcare Team, Astra Zeneca UK
Dario Neri,
Professor, Department of Chemistry and Applied Biosciences ETH Zurich
Martin Oleksiewicz,
Team Leader, Molecular Toxicology, Novo Nordisk A/S
Koustubh Ranade,
Director, Pharmacogenomics & Human Genetics, Pharmaceutical Research Institute, Bristol-Myers Squibb Company
Bjorn Riefke,
Head Laboratory Diagnostics Non-Clinical Drug Safety, Bayer Healthcare
Ronenn Roubenoff,
MD, Senior Director, Immunology Medical Research, Biogen Idec, Inc.
Hugh Salter,
Associate Director, Pharmacogenomics, Astra Zeneca
Michael Shi,
Director and Biomarker Project Leader of Exploratory Oncology Development, Novartis
Magnus Sjogren,
Associate Professor, Psychiatrist, Director Clinical Research CNS, N.V. Organon
Thomas Steger-Hartmann,
Head Lab Diagnostics Experimental Toxicology, Schering AG
Detlef Stiller,
Head, Invivo Imaging, Boehringer Ingelheim Germany
Stefan Sultana,
Translational Medicine Leader for GU Therapeutic Area, Pfizer
Jean Tessier,
Clinical Imaging Scientist, Discovery Medicine, Astra Zeneca
Alain van Gool,
Director Genomics & Proteomics N.V. Organon
George Wensing,
Head, Pharmacodynamics, Clinical Pharmacology, Bayer Healthcare
Paul Whiting,
Head of Biomarkers and Translational Biology, Discovery Biology, Pfizer
Media Sponsors
Home | Biomarkers 2008 | Programme | Event Format | Speakers | Delegates | Solution Providers | Media Partners | Press Centre | Testimonials | Venue | Organisers | Other Events | Contact | Book Online | 
© 3rd Annual Biomarkers Congress